President Joe Biden turned heads Sunday night when he declared the COVID-19 pandemic is “over” even while stating the United States is still having a “problem” with the virus. “The pandemic is over,” he said during an interview...
When it comes to the pandemic’s impact on academic achievement, no children are immune. But just as COVID-19 itself has hit underserved demographics the hardest, minority students in poorly equipped schools experienced the steepest slides in the national test-score...
When the pandemic started, Tomeka Kimbrough-Hilson knew she had a small growth inside her uterus. She was first diagnosed with uterine fibroids back in 2006 and had been able to have the non-cancerous mass removed through outpatient laser surgery. Over the years,...
The National Institute of Allergy and Infectious Diseases (NIAID) has earmarked $600 million to stop future pandemics before they start – and up to $3.8 million of that will go to a team led by Rutgers researcher Eddy Arnold. The plan is simple: Identify viruses with...
A new study is sure to add another layer of intrigue surrounding Pfizer’s COVID-19 pill Paxlovid. In the study, based on data collected from 109,000 patients at a large Israeli health system, the drug appeared highly effective in seniors. Researchers found that those...
